Neurogene Inc.
NGNE
$20.02
$0.784.05%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 5.87% | 23.01% | 32.04% | 25.96% | 40.32% |
| Gross Profit | -5.87% | -30.68% | -32.04% | -25.96% | -40.32% |
| SG&A Expenses | 11.23% | 26.34% | 55.77% | 141.86% | 63.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.29% | 23.85% | 38.69% | 46.01% | 45.74% |
| Operating Income | -7.29% | -29.54% | -38.69% | -46.01% | -45.74% |
| Income Before Tax | -3.64% | -19.06% | -33.84% | -918.88% | -38.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.64% | -19.06% | -33.84% | -918.88% | -38.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.64% | -19.06% | -33.84% | -918.88% | -38.69% |
| EBIT | -7.29% | -29.54% | -38.69% | -46.01% | -45.74% |
| EBITDA | -7.72% | -31.05% | -40.83% | -48.97% | -48.52% |
| EPS Basic | 17.00% | 4.21% | -7.75% | -101.23% | 96.35% |
| Normalized Basic EPS | 17.00% | 4.21% | -8.32% | 95.39% | 96.35% |
| EPS Diluted | 17.00% | 4.21% | -7.75% | -133.21% | 96.35% |
| Normalized Diluted EPS | 17.00% | 4.21% | -8.32% | -24.11% | 96.35% |
| Average Basic Shares Outstanding | 24.86% | 24.28% | 24.21% | 2,927.90% | 3,698.66% |
| Average Diluted Shares Outstanding | 24.86% | 24.28% | 24.21% | 12.52% | 3,698.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |